Drug Profile
Dapitant
Alternative Names: RPR 100893Latest Information Update: 08 Jul 2002
Price :
$50
*
At a glance
- Originator Aventis
- Class Isoindoles
- Mechanism of Action Neurokinin 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Migraine; Pain